Oral Aripiprazole Open-Label Rollover Study

NCT01001702 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.